GENEVA, May 16 -- EFFEPHARM (SHANGHAI) CO., LTD. (Room 201, Building 12, No. 1 Middle Wangdong Road, Sijing TownSongjiang District, Shanghai 201601), 音芙医药科技(上海)有限公司 (中国上海市松江区泗泾镇望东中路1号12幢201室) filed a patent application (PCT/CN2024/094493) for "AMORPHOUS FORM OF REDUCED Beta-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR" on May 21, 2024. With publication no. WO/2025/097718, the details related to the patent application was published on May 15, 2025.
Notably, the patent application was ...